Where the Money Goes

You are here

ALSF Childhood Cancer Research Grants

With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.

Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.

You can learn about ALSF's grant review process here.

Support This Research

Jump to search filters

ALSF Funded Research Projects

Project Title	Institution / Principal Investigator(s)	Grant Type	Year	State
Enhanced Drug Repurposing Screen in DSRCT Enabled by New In Vitro and In Vivo Models Based on CRISPR/Cas9 Genome Engineering	Memorial Sloan-Kettering Cancer Center / Marc Ladanyi, MD & Maria Jasin, PhD	Innovation Grants	2015	New York
High-dimensional Biochemical CyTOF Analysis of Pediatric T cell Leukemias	University of California San Francisco / Jeroen Roose, PhD	Innovation Grants	2015	California
Developing a Novel Tumor Model to Screen for New Therapies for Spinal Ependymoma	The Johns Hopkins University School of Medicine / Linda Resar, MD & Richard Schlegel, MD, PhD	Innovation Grants	2015	Maryland
Integrative Genomic and Immunogenomic Analysis of Neuroblastoma	University of California at Santa Cruz / David Haussler, PhD	Innovation Grants	2015	California
Identifying Epigenetic Mechanisms Impacting Neuroblastoma Genome Stability and Drug Response	Massachusetts General Hospital / Johnathan Whetstine, PhD	Innovation Grants	2015	Massachusetts
Optimizing Bispecific Antibody Therapy for Acute Leukemias	Fred Hutchinson Cancer Research Center / Roland Walter, MD, PhD & James Olson, MD, PhD	Innovation Grants	2015	Washington
Functional Analysis and Therapeutic Targeting of STAG2 Mutations in Ewing sarcoma	Georgetown University / Todd Waldman, MD, PhD	Innovation Grants	2015	District of Columbia
Identifying how Pre-existing Anti-Therapeutic Antibodies (PATA) are Associated with Better Outcome in a Clinical Trial of ADCC-inducing Anti-GD2 mAb	University of Wisconsin - Madison / Paul Sondel, MD, PhD	Innovation Grants	2015	Wisconsin
Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma	Children’s Hospital Los Angeles / Robert Seeger, MD & Alan Wayne, MD	Innovation Grants	2015	California
Preclinical Development of Atr Inhibitor VE-822, Delivered Systemically in Nanoparticles, for Medulloblastoma Therapy	University of North Carolina / Timothy Gershon, MD, PhD	Innovation Grants	2015	North Carolina

Pages